Fast-growing听HealthTech company Bond Digital Health has appointed a new CEO.听
Ian听Smith is an experienced company director who has held CEO and CFO roles in businesses in various sectors, including health technology, medical technology, biotech and finance.听
He听was most recently CEO of Time Finance plc, an AIM-listed company offering business finance solutions to SMEs.听
Throughout听his career Smith, a qualified chartered accountant, has helped businesses commercialise R&D, manage rapid growth, raise development capital, merge, and float on the stock exchange.听
He听takes over as CEO at Wales-based Bond Digital Health from its co-founder Ian Bond, who is stepping back to a part-time role,听acting as an ambassador for the business.听
Bond听has grown rapidly over the last 18 months as it developed its key product Transform, a data capture and reporting solution for lateral flow diagnostic tests.听
/healthtech-50/
Smith will be tasked with growing the business internationally and preparing it for further investment and in due course a potential public listing.听
鈥淏ond Digital Health is an impressive company with exciting prospects,鈥� he said.听
鈥淲e鈥檝e听seen in the pandemic how lateral flow tests have become a valuable and trusted diagnostic tool, but they are听analogue听and we know there will be huge demand for tests to be enabled with digital data capture and data management in future.听
鈥淔or听Bond, that means there is real opportunity for international growth across various markets and sectors. This is a business听whose听digital and data-led technology could become essential in diagnostics, not only in human and animal health, but also in growing听sectors such as environmental testing and food and drink safety.听
鈥淚听am very excited to be joining a very talented team in a business with significant potential.鈥�听
Outgoing听CEO Bond said: 鈥淚鈥檓 honoured to be handing over the reins to Ian. With his successful track record of transitioning companies from one stage of development to the next, he is the ideal person to lead the business into the next phase of our growth.听
鈥淲ith听products already in the market and global demand for our technology growing, the next couple of years will be crucial for the future of Bond Digital Health.听
鈥淚an鈥檚听experience, combined with his positivity and ambition are just what the business needs.鈥�听
Over听the course of 2020, Bond received almost 拢2 million in equity funding and more than 拢200,000 in UK and Welsh Government grants, which allowed it to expand its development team.听
Bond鈥檚听key product Transform is now in-market, adding digital connectivity and data capture to three different lateral flow tests – two antigen tests in the US and Canada and an antibody test in the UK.听
In听March, the business appointed Wayne Harvey, the Chair of Cardiff Airport, a partner at Gambit Corporate Finance and former Senior Managing Partner for Deloitte in Wales, as its non-executive director and Chair.